Key result
Pulmonary edema affects ~18% of women with severe maternal outcomes, driven largely by hypertensive disorders.
Why the study?
The incidence, outcomes, and potential modifiable factors of pulmonary oedema in women with severe maternal outcome during childbirth needed to be described.
Cohort (n=399)
Pulmonary oedema is a significant complication in women with severe maternal outcomes, often driven by pre-eclampsia and iatrogenic fluid overload, highlighting the need for careful fluid management and multidisciplinary care.
Pulmonary oedema affects ~18% of severe maternal outcomes; hypothesis-generating for fluid management in pre-eclampsia, warranting prospective evaluation.
OBJECTIVES: To describe the incidence and outcomes of pulmonary oedema in women with severe maternal outcome during childbirth and identify possible modifiable factors through audit. METHODS: All women with severe maternal outcome (maternal deaths or near misses) who were referred to Tygerberg referral hospital from health facilities in Metro East district, South Africa, during 2014-2015 were included. Women with severe maternal outcome and pulmonary oedema during pregnancy or childbirth were evaluated using three types of critical incident audit: criterion-based case review by one consultant gynaecologist, monodisciplinary critical incident audit by a team of gynaecologists, multidisciplinary audit with expert review from anaesthesiologists and cardiologists. RESULTS: Of 32,161 pregnant women who gave birth in the study period, 399 (1.2%) women had severe maternal outcome and 72/399 (18.1%) had pulmonary oedema with a case fatality rate of 5.6% (4/72). Critical incident audit demonstrated that pre-eclampsia/HELLP-syndrome and chronic hypertension were the main conditions underlying pulmonary oedema (44/72, 61.1%). Administration of volumes of intravenous fluids in already sick women, undiagnosed underlying cardiac illness, administration of magnesium sulphate as part of pre-eclampsia management and oxytocin for augmentation of labour were identified as possible contributors to the pathophysiology of pulmonary oedema. Women-related factors (improved antenatal care attendance) and health care-related factors (earlier diagnosis and management) would potentially have improved maternal outcome. CONCLUSIONS: Although pulmonary oedema in pregnancy is rare, among women with severe maternal outcome a considerable proportion had pulmonary oedema (18.1%). Audit identified options for prevention of pulmonary oedema and improved outcome. These included early detection and management of preeclampsia with close monitoring of fluid intake and cardiac evaluation in case of suspected pulmonary oedema. Therefore, a multidisciplinary clinical approach is recommended.
No takes yet. Share an insight, caveat, or question.
Heitkamp et al. (2023) conducted a cohort in Severe maternal outcome (SMO) and pulmonary oedema (n=399). Severe maternal outcome was evaluated on Incidence of pulmonary oedema in women with severe maternal outcome. Among women with severe maternal outcome, 18.1% developed pulmonary oedema, primarily driven by pre-eclampsia/HELLP-syndrome and chronic hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: